SC

Sriram Chandrasekaran

Active Director Director DIN 09217261
DIN 09217261 First appointment Jun 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Sriram Chandrasekaran

Data last updated:

Sriram Chandrasekaran is a Director at Bionyme Laboratories Private Limited (since 2021). The company operates in Healthcare. Bionyme Laboratories Private Limited reported revenue of ₹1.1 Lakh (FY 2023).

DIN 09217261
Primary Designation Director
Industry Healthcare
First Appointment 26 Jun 2021
Oldest Company Age 5 yrs
Largest company Bionyme Laboratories Private Limited · ₹1.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bionyme Laboratories Private Limited U85100TN2021PTC144340
Director26 Jun 20212021₹1.1 Lakh (FY 2023)Active

Board colleagues of Sriram Chandrasekaran

NameDINCompanyDesignation
Leeba Balan09217262Bionyme Laboratories Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Bionyme Laboratories Private Limited
Premium access

Shareholding and investment profile for Sriram Chandrasekaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriram Chandrasekaran

Sriram Chandrasekaran currently holds 1 directorship: Bionyme Laboratories Private Limited (Director, since 26 Jun 2021, revenue ₹1.1 Lakh (FY 2023)).

Sriram Chandrasekaran was first appointed on 26 Jun 2021 as Director at Bionyme Laboratories Private Limited.

The current boards of Sriram Chandrasekaran's companies include Leeba Balan (Bionyme Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available